Replies to Post #66595 onBlue Diamond Ventures Inc (BLDV)

Replies to #66595 on Blue Diamond Ventures Inc (BLDV)

07/03/17 8:33 AM

AWESOME compiling of DD Stervc! I agree, we are a big MMJ Conglomerate umbrella corp. When the Stars align we are in huge money! $BLDV

legacy1010

07/03/17 8:50 AM

#66599 RE: stervc #66595

Wowzers! Thank you sir!

JPS02

07/03/17 10:25 AM

#66613 RE: stervc #66595

Great and well articulated DD stervc that is a great read. I think everyone should re-read your amazing post to understand the immense amount of DD and insight you are sharing with us. Your post helps us better see the value being built here in BLDV.

The inherent diversification within BLDV that you point out at the beginning of your post is one of the reasons why I am a BLDV shareholder.

Thank you for sharing your thoughts with us.

Go BLDV!

JPS02

07/03/17 9:53 PM

#66664 RE: stervc #66595

5 reasons Israel is dominating the cannabis industry

From research to agricultural and technical innovation and liberal government policies, Israel is a central hub for advancing medical cannabis.

By Viva Sarah Press | February 13, 2017, 7:00 am

Legal cannabis sales across the world totaled $150 billion last year, and sales in the United States alone are expected to reach $21.8 billion by 2020.

Israel is at the center of this huge growth because of its well-developed ecosystem of cannabis researchers, farmers, entrepreneurs, pharma and government policies.

“You can’t put cannabis into a category. It’s not just pharma and it’s not just agro-tech. It’s not just lifestyle or recreational,” Saul Kaye, a pharmacist and the chief executive of iCAN: Israel-Cannabis venture fund, tells ISRAEL21c.

Kaye says Israel is up to 10 years ahead of other countries in innovation in the cannabis industry.

The Hebrew University of Jerusalem has a multidisciplinary center on cannabinoid research and Ariel University offers a course on the use of medical cannabis. The Volcani Agricultural Research Organization is building a national institute for medical marijuana research.

Startup accelerator Cann10 hosts an annual International Medical Cannabis Conference and iCAN hosts the annual CannaTech cannabis innovation summit. The next summit is set for March 20-22 in Tel Aviv.

The Israeli government announced last year that it will expand the number of doctors trained and authorized to prescribe medical marijuana. In January, the government announced plans to decriminalize personal marijuana use, and in February a government committee approved cannabis export.

“This change will significantly increase entrepreneurship and investment into cannabis in Israel as the old stigma of criminal cannabis disappears,” says Kaye.

Since the government’s mid-2016 reforms to open up licensing for as many marijuana growers as the market will support, over 200 individuals and groups have applied to join Israel’s current eight cannabis farms.

ISRAEL21c presents five reasons Israel is dominating the cannabis industry:

RESEARCH

CNN medical correspondent Dr. Sanjay Gupta called Israel “the medical marijuana research capital” in 2015. This didn’t happen overnight; Israel’s government has encouraged cannabis research since the 1960s.

Hebrew University Prof. Raphael Mechoulam, an Israel Prize winner, is credited with pioneering medical cannabis research 50 years ago. He isolated the active compound from cannabis, THC, and inspired generations of researchers in several countries.

Cannabis has been used in research to treat conditions including diabetes, Parkinson’s disease, epilepsy, myeloma, psoriasis, fibromyalgia, PTSD, cancer, multiple sclerosis (MS), chronic pain, and broken bones.

“Israel is one of the leading cannabinoid centers of research in the world. There are about two dozen groups working on it and people come from all around the world to see what we do,” Mechoulam told ISRAEL21c in 2012.

In January this year, the government announced it is investing $2.13 million in 13 research projects including the effect of cannabis on metabolic syndrome, MS, preventing transplanted organ rejection, and inhibiting the development of harmful bacteria.

GENETIC ENGINEERING

GMO may have a negative implication in food, but when it comes to medical marijuana, genetic engineering is deemed crucial for treating a range of diseases.

Israeli scientists are among the world leaders in modifying marijuana’s molecular structure to tailor cannabinoids to specific receptors for treating symptoms.

Hebrew University researchers synthesized 22 versions of the cannabinoid THC that have great potential for treating neurological and inflammatory diseases.

“The Hebrew University holds a rich IP bank of cannabis patents. It is easier to conduct cannabis research and clinical studies in Israel than in any other country in the world,” says Kaye.

AGRICULTURAL TECHNOLOGIES

Tikun Olam is the first and foremost supplier of medical cannabis in Israel, and one of the leading medical cannabis companies in the world. It has developed a range of proprietary varieties – perhaps up to 230 – used in clinical medical trials.

Existing growing technologies are being adapted to the marijuana crop, while new technologies are geared specifically to this healing plant.

Kaye points to drip irrigation as an example of old technology helping marijuana growers. “Companies like Netafim can adapt their technology to our needs,” he says. “For them, cannabis is just another crop.”

New entrepreneurs with agriculture technologies for the medical marijuana market include the Leaf home cultivation system and Flux’s IoT hydroponic gardening tool.

Using Flux’s smart device, Eddy, “you can dial in your favorite strain and Eddy will become your easy button, making that strain grow to perfection and according to your medical needs,” Flux founder and Marketing VP Karin Kloosterman tells ISRAEL21c.

PHARMA

In addition to decriminalizing personal marijuana use, the Israeli government is on a mission to regulate medical marijuana and make it more accessible and available by prescription at pharmacies.

“Cannabis should be considered, so far as possible, in the same manner as any other medicinal product, requiring supervision and regulation in order to protect public health and welfare, even when taking into account its special characteristics — being a plant rather than a product manufactured in a laboratory or factory,” according to the Health Ministry’s Medical Cannabis Unit.

OWC Pharmaceutical Research, a developer of cannabinoid-based therapies targeting a variety of different indications, and Breath of Life Pharma, which provides cannabis-based medical products and cannabinoid APIs (active pharmaceutical ingredients), are working with the Health Ministry, universities, medical institutions and researchers to develop cannabis-based pharmaceuticals and treatments.

International companies regularly join forces with Israeli academic and medical institutions to create new medications.

For example, Kalytera Therapeutics, a US company developing a new class of proprietary cannabidiol (CBD) therapeutics, recently licensed two synthetic cannabis derivatives from the Hebrew University’s technology transfer company Yissum, for eventual use in treating osteoporosis, bone fractures and other diseases.

“Medical cannabis is increasingly being used for a variety of indications, such as reducing nausea during chemotherapy and relieving pain and muscle spasticity in multiple sclerosis patients. Development of state-of-the art delivery systems for the active ingredients will undoubtedly pave the way for a wider variety of clinical indications for these types of drugs,” Yaacov Michlin, CEO of Yissum, told ISRAEL21c in 2015.

Kalytera also inked a multimillion-dollar deal to purchase Talent Biotech of Bnei Brak, a startup that won the pitch event at CannaTech 2016.

MEDICAL DEVICES

Once the cannabis has been grown, extracted and formulated, it needs a delivery system for proper dosage — a tablet, a patch, a nasal spray or a cigarette, for example. And that’s where Israeli ingenuity comes in.

Late last year, Teva Pharmaceutical Industries agreed to market medical cannabis for pain management in Israel with a revolutionary selective-dose pharmaceutical-grade medicinal plants inhaler from Tel Aviv-based Syqe Medical.

Israeli-American company Cannabics Pharmaceuticals is working to put the medicinal compounds of cannabis into a sustained-release capsule in standardized doses.

And Australia-based PhytoTech Medical is developing an adhesive patch with medical cannabis, based on Hebrew University technologies.

“Israel is way ahead in adaptable technologies for the industry in an industry that hasn’t yet created its own technologies,” says Kaye.

Source: https://www.israel21c.org/5-reasons-israel-is-dominating-the-cannabis-industry/

JPS02

07/05/17 9:45 PM

#66749 RE: stervc #66595

CannaTech 2017 - The Future of Medicine: Genetics Based Personalized Treatment - Dr. David Meiri

Published on Apr 19, 2017

Dr. David "Dedi" Meiri from the Cancer Research lab at the Technion in Israel (aka "Dedi's Lab") takes us through a fascinating presentation on the identification of the effects of different Cannabis extracts on the proliferation and cell death of various cancer cell lines (and classification) according to genetic profile.

1. I think this is a very interesting presentation that takes a few replays to understand because I am not a scientist or Doctor. However, notice Dr. Meiri is looking for a specific cannabinoid to combat the illness based on the research he started 2 years ago.

2. They are now able to take an extract and identify the cannabinoids and 20 different strains that can be prescribed to the patient. Dr. Mieri mentions that each strain is a different medicine. There is a specifity between what is in the cannabis and what is affecting the cells being treated.

3. 96 different treatments are being analyzed by Israeli researchers and it is very important that the right type of cannabis is used to combat different illnesses due to the different effectiveness of each strain of cannabinoids. There is at least 144 different cannabinoids.

4. They are noticing that there is variability in the effectiveness of different cannabis types grown in different greenhouses at different times.

Connections to BLDV

Notice at 5:50 in the June 1, 2017 interview how the BLDV CEO refers to grow operations being set up in Florida and how they are high tech. The CEO explains that in the MMJ industry they are more concerned with the exact complement of cannabinoids in the plant. Josh indicates it is more of a recipe relying on genetics and monitoring of controllable factors within controlled spaces.

BLDV's environmental control knowledge through their work with Zeno Controls and Verve Living Systems gave them the position to understand the total environment of the space. Josh indicates that in the MMJ industry, it is important to bring technology to different areas. Connect the dots!

I think as pharmaceutical companies introduce different cannabis extracts and doctors start prescribing different MMJ targeted to treat specific illnesses, they will require reliable cultivators that can control grow and environmental factors to ensure the right cannabinoids are provided in the right MMJ strain as part of a secure and safe MMJ supply on a consistent basis.

Hence, this is why I think BLDV's approach to partner with Israeli firms to secure multiple opportunities to bring Medical Cannabis products and technology to North America where AMS will implement the correct high tech cultivation methods as part of the integrated facility approach is timely and full of foresight of the future MMJ market. See further information provided in previous two posts:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132672130

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132701804

Go BLDV!

JPS02

07/06/17 5:13 PM

#66828 RE: stervc #66595

CannaTech 2017 - Yuval Landschaft, Director of Medical Cannabis Unit - Israel Ministry of Health

Published on Apr 19, 2017

Enjoy this inspiring address by the Director of the IMCA, the Israeli Medical Cannabis Agency, as he shares where Israel cannabis is headed (hint: it's all about medicalization).

1. See 4:36 for explanation of Cannacopia, 7:57 for GAP and GMP and 11:51 for contacts the Israeli Ministry of Health received from the UN and other nations wanting to see the GCP. To this end, notice how this aligns with what BLDV stated in the 6/28/17 PR that Medical cannabis standards are being implemented not only in the USA, but also in Europe, Canada and Mexico.

2. Note from the BLDV 6/28/17 PR, how BLDV is on the forefront of developments in technology and cannabis practices and standards to be able to state the following in the PR:

Blue Diamond Ventures Inc. (BLDV) and their wholly owned subsidiary Cannabis-Clean of Denver, will work with existing Israeli Cannabis Farms, Government Regulators, and third-party Certification Agencies to develop Sanitation and Anti-Bacterial protocols that will comply with the new GAP and GMP standards being developed in Israel.

Source: http://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures-Inc--announces-first-Israeli-Cannabis-Project?id=163387&b=y

Within the Health Ministry, Landschaft told participants how he spearheaded the creation of “the Torah of cannabis” regulation. Landschaft’s “Torah of cannabis,” which he also dubbed “Cannacopia,” contains five sections on Israel Medical Cannabis: IMC-GCP, IMC-GAP, IMC-GMP, IMCGDP and IMC-GSP (Good Clinical Practice, Good Agricultural Practice, Good Manufacturing Practice, Good Delivery Practice and Good Safety Practice).

Source: http://www.jpost.com/Israel-News/Medical-grade-cannabis-products-to-be-available-in-less-than-a-year-484701

Go BLDV!

JPS02

07/08/17 8:37 AM

#66915 RE: stervc #66595

Michigan Plant Technologies LLC (MPT) - Breakdown

(100% wholly owned subsidiary)

MPT continues to acquire licenses and distribution contracts for national and regional brands in the Cannabis Space. The goal is to place these agreements with the strategic partners in the Michigan Cannabis Real Estate project mentioned above.

Brands include [1-3]:

1. JuJu Joints - sleek, discreet, cannabis vaporizing e-joint http://www.jujujoints.com/home

2. AgriHit -- Natural Plant Growth & Health Enhancer a true "green" product, and made from plant extracts approved by the FDA, http://www.agrihit.com/,

3. Medtiva / MED-a-mints -- convenient and discreet. Each mint provides a dependable 10mg dose of THC making it easy to maintain the right medication level, http://medamints.com, Rela Dosage Control, and more.

4. R&D - "Our R&D facility in Michigan has proved to be instrumental in securing partners in this space," said Alper. "The ability to help our clients make prototypes of medicated products in a controlled environment using organically grown cannabis is enabled by the fact that the MPT Kitchen is a licensed Food Processing Facility in the State of Michigan that also produces products for the Bot Bakery."

Source: http://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures-Inc--Outlines-Operational-Strategies-for-2017?id=157095&b=y

Go BLDV!

JPS02

07/08/17 4:03 PM

#66919 RE: stervc #66595

Blue Diamond Consulting LLC (BDC)

100% wholly owned subsidiary

"Everything we do at BLDV starts with consulting," says Jonathan Alper, Manager of BDC and the Principle of Alper & Associates Consulting. "Land Development for Religious Organizations, including the development of the first residential projects built on leased land in Illinois, is still 50% of our business."

BDC has just secured a new contract to do the Master Planning and Project/Construction Management for 100 Acres of land owned by the Victory Christian Center in Pendleton NY, right outside of Buffalo. "We are seeing the results of partnering with BLDV, with the acquisition of this new client and contract," says Jonathan Alper a licensed Landscape Architect and a member of Lambda Alpha.

In addition to the Planning and Construction projects, Blue Diamond Consulting is responsible for the business development activities of all other BLDV business units and has several private clients in the cannabis space.

Source: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures-Inc--Outlines-Operational-Strategies-for-2017?id=157095&b=y

JPS02

07/11/17 8:52 PM

#67062 RE: stervc #66595

http://www.cannabis-clean.com
http://www.clean1st.com
https://www.facebook.com/CannaClean/

Second Cannabis Cup in Everett ,WA!!!#CannabisCup #cannabis #Seattle pic.twitter.com/Lkue88TuT6
— Cannabis Clean (@CannabisClean) September 7, 2014

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126066472
https://www.facebook.com/108751362804882/photos/a.108785682801450.1073741827.108751362804882/434366133576735/?type=3&theater

7. BDC NY Solar Project: BDC is working on a community solar project in Western New York as per 10/26 PR

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126066472

8. BDC Consulting to MJ clients in Michigan: Signed multiple clients pursuing marijuana licenses under the new laws in Michigan as per 10/26 PR.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126066472

9. BDC Consulting to California Lights Works Cannabis LED Lighting: Signed a short-term consulting agreement with a Cannabis Greenhouse Systems as per 10/26 PR

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126066472

10. Collaboration with JUJU Joints: Vaporizer model is sold out online and BLDV presented products in Orlando in May 2016

http://www.jujujoints.com/juju
http://www.jujujoints.com/rx
https://www.facebook.com/permalink.php?story_fbid=253984474948236&id=108751362804882
http://www.bd-suiteofservices.com/attorneys.html
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126024509

11. Bot Bakery division of Michigan Plant Technologies: A 100% wholly owned subsidiary of Blue Diamond is an organic, vegan and gluten-free bakery and kitchen. Bot Bakery is working towards opening its 1st retail store in Chicago in the summer of 2017.

https://www.facebook.com/permalink.php?story_fbid=434293313584017&id=108751362804882
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131124591

12. 5/26/17 PR: Blue Diamond Ventures Inc. announces a strategic partnership with Eltron Research & Development of Boulder Colorado, the creators of the ImPAAct™ Peracetic Acid Generator: Eltron R&D specializes in Material Sciences and adds considerable strength to BLDV on multiple levels. Eltron R & D and BLDV join forces to make an ImPAAct(TM) (PAA) in the Cannabis Industry

5/26 PR: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures-Inc--announces-Strategic-Partnership?id=160232&b=y

Stervc's insight on Eltron:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131699192
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131716420
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131728225
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131716261
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131813616

Other thoughts:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131840197

Go BLDV!

JPS02

07/12/17 8:34 PM

#67104 RE: stervc #66595

Blue Diamond Ventures Inc. announces Strategic Partnership

Eltron R & D and BLDV join forces to make an ImPAAct(TM) (PAA) in the Cannabis Industry

DENVER, CO--(Marketwired - May 26, 2017) - Blue Diamond Ventures Inc. (OTC PINK: BLDV) today announces a strategic partnership with Eltron Research & Development of Boulder Colorado, the creators of the ImPAAct™ Peracetic Acid Generator. Eltron R&D specializes in Material Sciences and adds considerable strength to BLDV on multiple levels.

Cannabis-Clean, a wholly owned subsidiary of BLDV, will work closely with Eltron R&D to roll out the PAA. "This is an exciting new offering; Peracetic Acid is widely used in Cannabis and other industries," said Josh Alper, CEO of BLDV. "The generator is a Patented Device, the only one of its kind, that makes the PAA product on site, on demand."

Steve McMorrow, President of Cannabis-Clean, said, "We are getting up to speed quickly; this agreement gives us the exclusive for the Cannabis Industry in Colorado with a commitment to define expansion to include a partnership for the entire USA." On June 1st, 2017 Cannabis-Clean will be relocating its operations to the Eltron R&D facility in Boulder. "The ImPAAct™ product has really defined our expansion strategy," continued McMorrow. "We have been working with Eltron for 6 months to put this together, and it gives us a sustainable competitive advantage." The new Peracetic Acid Generator has already been approved by the Colorado Department of Agriculture for use in Cannabis Facilities.

BLDV has been named the Representative of Eltron for Israel and Canada and will be facilitating the licensing of the PAA technology in those countries. Blue Diamond Ventures will also use the expertise of Eltron to help achieve the goal of bringing Targeted Cannabis Therapies from Israel to the USA and to Canada as part of the previously announced venture with AMS of Hanover, Canada.

"Eltron R&D provides the laboratory space, the chemists and the material scientists that complete the needs of our partners in Israel," says Josh Alper. "I will be back in Israel next week to finalize our first technology sharing agreements." BLDV will be moving their corporate headquarters into the Eltron space in Boulder in July 2017, joining Cannabis-Clean as part of the agreement.

About BLDV:

Blue Diamond Ventures, Inc. seeks to partner with individuals and companies that share a common synergy, mission and vision to enable products/services that are produced, delivered and consumed utilizing fewer natural resources, providing a sustainable alternative to traditional products on the market today. As a diversified customer, Centric Management / Holding Company, Blue Diamond Ventures, Inc. seeks opportunities in various markets and is driven by critical thinking and the scientific method.

About Eltron:

Eltron Research & Development was founded in 1982 and is a leading R&D organization with over 3 decades of experience providing technology solutions to industry. Our excellent track record of creating commercial-ready technologies has produced 3 spin-off companies and 77 patents, of which 29 have been licensed to industry. Eltron's staff consists of scientists and engineers (Ph.D., MS and BS level) who work in our state-of-the-art research facility in Boulder, Colorado. Eltron's core strengths are applied chemistry and engineering in the following technology areas:
•Energy and Fuels: Clean and sustainable energy, novel biofuels synthesis, fuel reforming, gasification and sequestration
•Catalysts: Design, synthesis, evaluation and scale-up of heterogeneous and homogeneous, supported and unsupported materials
•Advanced Materials: Polymers, membranes, multifunctional composites, ceramics, novel paints and coatings, chemical energy storage systems, materials molding and nanotubes
•Chemicals & Chemical Processing: Ambient and high temperature chemical processes as well as electrochemical methodologies
•Environmental: Green electrolytic water treatment technology, contaminant remediation, and sensor technology platforms

Eltron's clients come from both private and public sectors. Eltron has completed more than 200 projects over 3 decades for many government agencies including the DOE, DOD, NASA, EPA, NIH and NSF.

Safe Harbor:

This press release contains forward-looking statements. Such forward-looking statements are subject to several risks, assumptions, and uncertainties that could cause the Company's actual results to differ materially from those projected in such statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly revise any forward-looking statements.

Contact:
Blue Diamond Ventures Inc.
Joshua B. Alper
CEO
(844) 637-6377
info@bldvinc.com
www.bldvinc.com

Contact:
Eltron Research & Development Inc.
4600 Nautilus Court South
Boulder, CO 80301-3241
Telephone: (303) 530-0263
www.eltronresearch.com

Copyright © 2017 Marketwired. All Rights Reserved

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Source: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures-Inc--announces-Strategic-Partnership?id=160232&b=y

JPS02

07/13/17 9:11 PM

#67188 RE: stervc #66595

AMS is in the final stage to gain a full license to grow, market and sell medicinal cannabis products via Health Canada. BLDV has been working with AMS over the last year to finalize funding for its Fifty (50) thousand square foot cultivation facility.

"There has been recognition, by the Canadian Government, for the need to allow import and export in this industry," says Joshua B. Alper, CEO of BLDV. "This new effort will ensure that AMS, when licensed, will be a Global Project, with their products being available worldwide and with access to the ingredients and technology that will continue to make AMS a leader in the Canadian market." "We are excited to launch this effort with BLDV," said Joseph Groleau, VP Business Development for AMS.

"With the specialized products and technologies coming into Canada from Israel, and access to global markets with our finished products, we see this as a separate profit center that could even outgrow our efforts in cultivation." Canada will be the home to the new joint venture, and the first market focus will be to bring Israeli Cannabis products and technology to Canada. "AMS is the perfect partner for this project," said Joshua B. Alper, CEO of Blue Diamond Ventures, Inc. "They have a great team at AMS that has been challenged by the ever-shifting landscape of compliance and financial requirements, this project can create significant revenue even prior to AMS receiving the cultivation and manufacturing licenses from Health Canada."

Source: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures--Inc--launches-International-Cannabis-Project-with-AMS-Canada?id=156512&b=y

JPS02

07/17/17 9:47 PM

#67486 RE: stervc #66595

BLDV + Israel + Eltron Research + Global Market for Cannabis: What we know so far

1. Facebook - 3/20/17: BLDV discloses that Joshua B. Alper, CEO of Blue Diamond Ventures, Inc. is attending the 2017 CannaTech event on March 20 - 22, 2017

CannaTech is an annual event hosted in Israel, the heartland of innovation. CannaTech is designed to bring together the world’s most dynamic cannabis professionals for a rare chance to network, kick around conventional thinking about medical cannabis.

CannaTech showcases the full spectrum of global industry leaders, spanning the fields of science, research, finance, medicine, government policy, tech innovation, agriculture & entrepreneurship, at one outstanding event with a singular focus on cannabis and all the opportunity that surrounds it.

- Note the key highlights and how they are trying to describe the caliber of this event and in turn BLDV's intentions of attending the event
Here are the highlights from Cannatech 2017:

Source: https://www.facebook.com/108751362804882/photos/a.108785682801450.1073741827.108751362804882/411598989186783/?type=3&permPage=1

2. 4/26/17 PR and 5/3/17 Facebook: BLDV discloses that Jonathan Alper, Manager of Blue Diamond Consulting LLC and Principle of Alper & Associates Consulting, is traveling to Israel on Thursday, May 5th as an official representative of BLDV.

Mr. Alper will be meeting with government officials, and current & prospective clients to fully understand the logistics of importing/exporting cannabis products to and from Israel.

“I have done business in Israel for over 40 years,” said Alper “Regulatory Compliance is key, we will now start to coordinate our efforts with Health Canada, and the Israeli Health Ministries, Cannabis Unit”

- Notice how: i) There is explicit disclosure of the purpose of Jonathan's trip to Israel and how it relates to importing/exporting.

ii) The disclosure is not to discuss possibilities, but to discuss logistics and starting coordination thereby possibly indicating at how far they could be in the process

iii) There is explicit disclosure that Jonathan is travelling to Israel as an official representative. Official representatives are normally authorized to transact and engage in on behalf of who they represent, i.e. BLDV:

Sources: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures-Inc--Outlines-Operational-Strategies-for-2017?id=157095&b=y

https://www.facebook.com/permalink.php?story_fbid=433462800333735&id=108751362804882

State of Israel - Ministry of Health: Medical Cannabis Unit

The Medical Cannabis Unit is the authorized body in the Ministry of Health to issue patients with permits to use cannabis for medical purposes, in accordance with the Procedures that have been set (link to Procedure 106), to assess authorization and to issue appropriate permits to those engaged in the field of cannabis and to investigators and various research bodies that wish to carry out studies of cannabis and cannabinoids.

Source: https://www.health.gov.il/English/MinistryUnits/HealthDivision/cannabis/Pages/default.aspx

3. 4/26/17 PR and 5/3/17 Facebook: BLDV discloses that on May 28th, 2017, Joshua B. Alper CEO of Blue Diamond will be returning to Israel to conduct the next round of meetings on the Technology & Science side.

“We have the MJ Daily on May 16th, the LIFT Show in Toronto May 26th, and then back to Israel on May 28th, “says Josh “The timing could not be better”

- Note the timing of the trips from #2 to #3 and then how it falls after the Lift Show. Also, the post explicitly states that it is the next round of meetings. I think this is another possible indication of how far they could possibly be in the process.

Sources: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures-Inc--Outlines-Operational-Strategies-for-2017?id=157095&b=y

https://www.facebook.com/permalink.php?story_fbid=433462800333735&id=108751362804882

4. 4/20/17 PR: Key excerpts are: i) BLDV has entered into a Joint Development Agreement with Alternative Medical Solutions Inc., to import & export Targeted Medicinal Cannabis Products and Advanced Cannabis Technologies, to and from Canada.

- I do not think BLDV and AMS would enter into a JV if they were not possibly sure of the road they are taking with each and into other countries

ii) The recent CannaTech Conference in Israel provided the forum to secure the initial agreements required to pursue this effort

- Further to 4.i above, I think BLDV could be telling us that they have agreements in Israel to support/demand the other side of the JV with AMS

iii) This new effort will ensure that AMS, when licensed, will be a Global Project, with their products being available worldwide and with access to the ingredients and technology that will continue to make AMS a leader in the Canadian market."

- Further to 4.ii above, I think BLDV could be telling us that they will equip AMS with the necessary ingredients and technologies (hint: Israel) to become a player in the Global and Canadian market, thereby solidifying the need of both AMS and Israel Cannabis for each other

iv) "We are excited to launch this effort with BLDV," said Joseph Groleau, VP Business Development for AMS. "With the specialized products and technologies coming into Canada from Israel, and access to global markets with our finished products, we see this as a separate profit center that could even outgrow our efforts in cultivation."

- Further to 4.iii above, I think AMS could be trying to highlight the significance of the JV and how their ability to access and export global markets might be bigger than cultivation

v) Canada will be the home to the new joint venture, and the first market focus will be to bring Israeli Cannabis products and technology to Canada. "AMS is the perfect partner for this project," said Joshua B. Alper, CEO of Blue Diamond Ventures, Inc.

- Notice how the CEO BLDV is re-emphasizing the importance of the JV to bring Israeli products and technology to Canada but also indicating it will be the first market focus. It is possible that BLDV is planning to export to other markets after they succeed in the Israeli and Canadian markets in order to possibly become a Global Exporter.

Source: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures--Inc--launches-International-Cannabis-Project-with-AMS-Canada?id=156512&b=y

5. 5/10/17 Facebook: BLDV confirms that Jonathan Alper, Blue Diamond Director has been in Israel for the past few days conducting meetings on behalf of BLDV.

- Good to the see follow through on #2 that the trip took place in the same capacity BLDV indicated Jonathan would.

Source: https://www.facebook.com/permalink.php?story_fbid=436280033385345&id=108751362804882

Check out this CNN documentary on Israel's Cannabis Research and the science behind the research:

Israel : World capital of Cannabis Research

6. 5/26/17 PR: Blue Diamond Ventures Inc. announces a strategic partnership with Eltron Research & Development of Boulder Colorado, the creators of the ImPAAct™ Peracetic Acid Generator : Eltron R&D specializes in Material Sciences and adds considerable strength to BLDV on multiple levels.

- The key disclosures in this PR are that:

i) BLDV has been named the Representative of Eltron for Israel and Canada and will be facilitating the licensing of the PAA technology in those countries.

ii) Blue Diamond Ventures will also use the expertise of Eltron to help achieve the goal of bringing Targeted Cannabis Therapies from Israel to the USA and to Canada as part of the previously announced venture with AMS of Hanover, Canada.

http://www.eltronresearch.com

- Eltron's technology includes: IMPAACT™ Generator

The ImPAAct reactor from Eltron Water Systems is a patent-pending product to meet your disinfection, bleaching, or chemical oxidation needs. ImPAAct is an onsite reactor that quickly generates peracetic acid (PAA) at concentrations up to 3.5% from concentrated feedstock chemicals. The ImPAAct reactor also has the ability to blend hydrogen peroxide, sulfuric acid, and acetic acid to match the chemistry of equilibrium PAA and the ability for pH adjustment. The ImPAAct works with process streams that have a broad pH range and at temperatures less than 55°C.

Sources: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures-Inc--announces-Strategic-Partnership?id=160232&b=y

https://www.facebook.com/permalink.php?story_fbid=443162249363790&id=108751362804882

7. 6/12/17 PR: Blue Diamond Ventures Inc, Restructures around Israeli Cannabis Opportunities - Key highlights:

i) Blue Diamond has secured multiple opportunities to bring Medical Cannabis products and technology to North America.

- I think this part of the PR is trying to tell us that BLDV has set the stage and has the mechanisms in place to be able to sell products and technology to North America.

ii) Israel has a Startup mentality and companies there understand the need to move quickly said Josh Alper CEO of BLDV, but realistically it is not simple to do business there, we have 40+ years experience with the politics and the culture of the area, combined with the scientific knowledge that is required

- The four bolded words in blue are key in this part, the first three are Josh and Jonathan the fourth is Eltron Research. I think this part of the PR is trying to emphasize the challenges of operating in Israel, yet in #1 they mention that they have secured multiple opportunities, so I think they are trying to tell us they succeeded despite the challenges; i.e. they have the key success factors. Time will tell.

iii) The tradition pharma industry hopes to change the approach to the medical cannabis industry by leveraging clinical trails preformed in Israel, but at the same time the Cannabis plant is changing the industry by achieving real success with less than pharmaceutical grade products.

- I find this part interesting in terms of how often they are mentioning the pharmaceutical industry. Also, notice how the effects of the Cannabis plant on the traditional industry is highlighted. I wonder if they are trying to tell us something about the caliber or size of partnerships they have secured that want in due to the fact that cannabis is changing the industry. Time will tell.

- Finally, remember that Josh told us in the last interview that Israel is the only country in the world that has clinical trials on humans for cannabis. I find it interesting that this is mentioned again in the PR.

iv) Blue Diamond will create a wholly owned subsidiary Blue Diamond Technologies LLC to focus on these opportunities, this unit will be based in Toronto, details of the new structure and specifics on the agreements from Israel will be released during the conference call.

- Key word here is technologies. I think this part is telling us that the technologies they now have access to are significant enough to require a subsidiary on their own. Also, the Toronto headquarters is interestingly close to AMS in Hannover, Ontario. Equally important is that the details on the Israeli agreements will be announced in the Conference call.

Source: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures-Inc--Restructures-around-Israeli-Cannabis-Opportunities-?id=161722&b=y

Go BLDV!

JPS02

07/19/17 6:32 PM

#67690 RE: stervc #66595

Blue Diamond Ventures Inc. Updates Partners & Shareholders

BLDV Provides Mid-Year Project Updates and Projections for 2018

July 17, 2017 Blue Diamond Ventures Inc. (OTC PK: BLDV) – Denver Colorado:

Blue Diamond Ventures Inc. (BLDV) and their wholly owned subsidiaries continue to focus on the Medical Cannabis Industry in North America. Below are brief descriptions of the activities of the operating companies of BLDV

Blue Diamond Consulting LLC – is building strong connections in Israel that will be the focus of our consulting operations in 2018 and beyond. The wealth of knowledge, technology and experience that has been made available in Israel is unparalleled. Targeted Cannabis Therapies and Patented Drug Delivery Devices are among the efforts being secured for licensing and distribution in North America. The ZENO & Verve Living Systems are being repurposed for the Cannabis Industry and Blue Diamond Consulting is currently assisting the BLDV legal team with the preparation of the Private Placement Memorandum that will finalize the parameters of the investment into AMS Farms (see below, AMS will retain their own debt and BLDV will not have liability for the 12 Million loan).

AMS Farms Canada – BLDV remains confident in the acquisition of AMS as a wholly owned subsidiary, the proposed project structure will use technology, genetics and processes sourced from Israel to gain a competitive advantage in the Canadian Market. Our Strategic Partnership with AMS is an important part of our Canadian Strategy overall and our commitment to them as a Joint Venture Partner for future development is intact. As recreational products start to dominate the scene in Canada, we believe that our focus on the new Cannacuetical, medical applications will reap significant rewards and market share by targeting specific conditions and patient needs. The Canadian market is well ahead of the US on clinically verified therapies, and Toronto will be the new home of Blue Diamond Technologies, the proposed Canadian trading entity.

Clean 1st LLC / Cannabis-Clean of Denver – has begun working on the next generation of cleaning and sanitation standards for the Cannabis Industry in conjunction with the work that is being done in Israel. In partnership with Eltron Research & Development, Cannabis Clean is commercializing the ImPAAct™ Peracetic Acid Generator and associated processes for Cannabis Businesses. Cannabis Clean will use the PAA technology to drive the national and international expansion of the company.

Cannabis Real Estate Fund – the scope of this project has been expanded to include facilities outside of Michigan, the Michigan Project Group will remain as a focused component of the fund and the priority of the monies raised upon launch. The project will raise $10 Million over the next 18 months. The fund will be cleared to accept investments on Tuesday September 5th, 2017 and will be actively seeking accredited investors. Blue Diamond Consulting has the exclusive for all Project Management & Construction Management on the Projects.

Michigan Plant Technologies LLC – MPT and its retail operations BOT Bakery and the bettyBOT SHOP continue to make progress in Chicago. The bettyBOT SHOP has received the final approval from the Chicago Health Department and is already producing wholesale products, the retail store will be open on Aug 4th, 2017.

NOW Brands – Has successfully launched the new packaging in New York to critical acclaim, and has secured commitments for retail locations in Colorado. Plans for 2018 include expanding production, expanding distribution not only to Colorado, but Florida and Texas are expected to be online by the end of 2018. Now Brands is seeking equity partners to expand the brand nationally.

About BLDV:

Blue Diamond Ventures, Inc. seeks to partner with individuals and companies that share a common synergy, mission and vision to enable products/services that are produced, delivered and consumed utilizing fewer natural resources, providing a sustainable alternative to traditional products on the market today. As a diversified customer, centric Management / Holding Company; Blue Diamond Ventures, Inc. seeks opportunities in various markets and is driven by critical thinking and the scientific method.

Safe Harbor:
This press release contains forward-looking statements. Such forward-looking statements are subject to several risks, assumptions, and uncertainties that could cause the Company's actual results to differ materially from those projected in such statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly revise any forward-looking statements.

Contact:
Blue Diamond Ventures Inc.
535 N. Michigan Avenue, Suite 3001, Chicago, Illinois, 60611
Joshua B. Alper Chief Executive Officer
(844) 637-6377 info@bldvinc.com www.bldvinc.com

Source - 7/17/17 PR: https://www.otcmarkets.com/ajax/showNewsReleaseDocumentById.pdf?id=26412

Go BLDV!

JPS02

07/28/17 7:31 PM

#68352 RE: stervc #66595

mikeski74

08/02/17 10:16 PM

#68740 RE: stervc #66595

Wow!! I would be so happy if we hit half that evaluation. Good times ahead for BLDV

emit

08/03/17 1:05 AM

#68741 RE: stervc #66595

Hope the private partner comes thru...

Creating September Projects

emit...

JPS02

08/05/17 8:27 AM

#68823 RE: stervc #66595

AMS is in the final stage to gain a full license to grow, market and sell medicinal cannabis products via Health Canada. BLDV has been working with AMS over the last year to finalize funding for its Fifty (50) thousand square foot cultivation facility.

"There has been recognition, by the Canadian Government, for the need to allow import and export in this industry," says Joshua B. Alper, CEO of BLDV. "This new effort will ensure that AMS, when licensed, will be a Global Project, with their products being available worldwide and with access to the ingredients and technology that will continue to make AMS a leader in the Canadian market." "We are excited to launch this effort with BLDV," said Joseph Groleau, VP Business Development for AMS.

"With the specialized products and technologies coming into Canada from Israel, and access to global markets with our finished products, we see this as a separate profit center that could even outgrow our efforts in cultivation." Canada will be the home to the new joint venture, and the first market focus will be to bring Israeli Cannabis products and technology to Canada. "AMS is the perfect partner for this project," said Joshua B. Alper, CEO of Blue Diamond Ventures, Inc. "They have a great team at AMS that has been challenged by the ever-shifting landscape of compliance and financial requirements, this project can create significant revenue even prior to AMS receiving the cultivation and manufacturing licenses from Health Canada."

Source: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures--Inc--launches-International-Cannabis-Project-with-AMS-Canada?id=156512&b=y

JPS02

08/06/17 8:36 PM

#68845 RE: stervc #66595

Key highlights from BLDV 6/12/17 PR:

Blue Diamond Ventures Inc, Restructures around Israeli Cannabis Opportunities

1. Blue Diamond has secured multiple opportunities to bring Medical Cannabis products and technology to North America.

- I think this part of the PR is trying to tell us that BLDV has set the stage and has the mechanisms in place to be able to sell products and technology to North America.

2. Israel has a Startup mentality and companies there understand the need to move quickly said Josh Alper CEO of BLDV, but realistically it is not simple to do business there, we have 40+ years experience with the politics and the culture of the area, combined with the scientific knowledge that is required

- The four bolded words in blue are key in this part. The first three are Josh and Jonathan and the fourth is Eltron Research. I think this part of the PR is trying to emphasize the challenges of operating in Israel, yet in #1 they mention that they have secured multiple opportunities, so I think they are trying to tell us they succeeded despite the challenges; i.e. they have the key success factors. Time will tell.

3. The tradition pharma industry hopes to change the approach to the medical cannabis industry by leveraging clinical trials preformed in Israel, but at the same time the Cannabis plant is changing the industry by achieving real success with less than pharmaceutical grade products.

- I find this part interesting in terms of how often they are mentioning the pharmaceutical industry. Also, notice how the effects of the Cannabis plant on the traditional industry is highlighted. I wonder if they are trying to tell us something about the caliber or size of partnerships they have secured that want in due to the fact that cannabis is changing the industry. Time will tell.

- Finally, remember that Josh told us in the last interview that Israel is the only country in the world that has clinical trials on humans for cannabis. I find it interesting that this is mentioned again in the PR.

4. We now have access to a range of genetics, protocols, devices, and technologies that can be licensed now to operators in Canada in partnership with AMS, and offered to Best in Breed operators in all 50 states continued Alper, in addition we have started talks with a group in Mexico City to leverage the new laws there.

- I think this part is loaded:

i) I think they are setting the stage to let us know the types of products and technologies they now have access to license to Canadian customers in partnership with AMS. Key here is the AMS JV; it's as if AMS is more significant than it seems. Remember that Josh mentioned in the last interview that building revenues is their goal, i.e. licensing revenues.

ii) Plus they mention that they can offer these products and technologies to operators in the U.S., notice how they mention states. I am guessing here that they are trying to indicate that regardless of state laws, the operators will/can need/buy these valuable products and technologies.

iii) Mexico City is something we have not heard about yet and I think it speaks strongly to the worldwide appeal and international growth of cannabis that we have been reading about in the DD. BLDV is going more international and it begs the question as to what BLDV has that would interest potential customers/partners even in Mexico. Also, I find it impressive as to how they stay on top of the changing legislative environment for cannabis in North America.

5. Blue Diamond will create a wholly owned subsidiary Blue Diamond Technologies LLC to focus on these opportunities, this unit will be based in Toronto, details of the new structure and specifics on the agreements from Israel will be released during the conference call.

- Key word here is technologies. I think this part is telling us that the technologies they now have access to are significant enough to require a subsidiary on their own. Also, the Toronto headquarters is interestingly close to AMS in Hannover, Ontario. Equally important and significant is that the details on the Israeli agreements will be released during the Conference Call.

Source: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures-Inc--Restructures-around-Israeli-Cannabis-Opportunities-?id=161722&b=y

Overall: I think this PR is following through in general on BLDV's efforts in Israel and sets the stage for future updates in regards to BLDV's integrated approach to cannabis. Notice how the parts above all fit together. To this end, remember the entire facility approach that Josh mentioned in the last interview.

I think people will realize that BLDV is not your traditional hyped up ticker with significant PRs that cause pps spikes. From the last interview, we know that Josh has a long-term view to build a solid corporation with long-term pps value growth. Therefore, I think this PR is setting the stage to continue to build the integrated approach to cannabis and to build value into BLDV with the pps eventually reflecting this value, not the other way around.

Go BLDV!

JPS02

08/06/17 8:39 PM

#68846 RE: stervc #66595

Key highlights from BLDV 6/21/17 PR:

Blue Diamond Ventures, Inc. Provides Updates on Michigan Growth Fund

Joshua Alper CEO of BLDV outlines plans for the Michigan Growth Fund

June 21, 2017 Blue Diamond Ventures Inc. (OTC PK: BLDV) – Denver Colorado:

Blue Diamond Ventures Inc. (BLDV) has announced the launch of Michigan Growth LLC.

Michigan Growth LLC will fund the construction of multiple cannabis real estate properties, then lease the buildings to licensed Commercial Cannabis Growers in South West Michigan.

Blue Diamond has adopted a unique approach to Cannabis Real Estate in Michigan using Triple Net Leases, Medical Focus, and Public Share involvement. The Fund is projected to raise approximately $10 Million USD. Blue Diamond shares issued to investors for this project will be issued with a SIX (6) YEAR RESTRICTION, the investment is in a limited partnership in the buildings themselves and the stock represents a parallel path for investors to benefit. The Plans include an estimated twelve projects, along the Route 12 corridor from New Buffalo to Niles MI. This project is expected to provide economic growth and much need jobs for this region.

“Over the past several months, I have attended municipal meetings, met with city managers and city planners from multiple towns and villages. As a result, we have been able to identify several locations suitable for medical cannabis facilities, and we are actively pursuing those opportunities. In addition, we have several leases lined up, ready to rent space once buildings are completed.” Said Josh Alper CEO of BLDV.

Jonathan Alper Board Member and Licensed Landscape Architect also commented: “I have reviewed the sites that Josh has designated as possible locations for the Michigan Growth to build medical cannabis real estate projects on, and there is a synergy between the towns involved in this effort. We hope to create sort of a “Emerald Rectangle” in Southwest Michigan. This type of project truly plays to our strengths as an organization”

Blue Diamond is working closely with Jillian Sidoti, of Trowbridge Sidoti LLP to develop the Michigan Growth investment package and we expect to launch the fund within the month of July. Additional updates will follow soon.

About BLDV:

Blue Diamond Ventures, Inc. seeks to partner with individuals and companies that share a common synergy, mission and vision to enable products/services that are produced, delivered and consumed utilizing fewer natural resources, providing a sustainable alternative to traditional products on the market today. As a diversified customer, centric Management / Holding Company; Blue Diamond Ventures, Inc. seeks opportunities in various markets and is driven by critical thinking and the scientific method.

Safe Harbor:
This press release contains forward-looking statements. Such forward-looking statements are subject to several risks, assumptions, and uncertainties that could cause the Company's actual results to differ materially from those projected in such statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly revise any forward-looking statements.

Contact:
Blue Diamond Ventures Inc.
535 N. Michigan Ave. Suite
Joshua B. Alper CEO
(844) 637-6377 info@bldvinc.com www.bldvinc.com

Source: http://www.otcmarkets.com/ajax/showNewsReleaseDocumentById.pdf?id=26061

JPS02

08/06/17 8:41 PM

#68847 RE: stervc #66595

Key highlights from BLDV 7/31/17 PR:

Blue Diamond Ventures Inc. Adds Three to Advisory Board

- Below are my thoughts on what I think is another loaded PR from BLDV demonstrating how BLDV's developing advisory board requirements are relevant follow through's on previous PRs.

BLDV Prepares for September Projects with Strategic Additions

- I think this subtitle is a key indicator of upcoming projects in September which I am presuming will be announced. This is my favour part of the PR. Key word is September.

July 31, 2017 Blue Diamond Ventures Inc. (OTC PK: BLDV) – Denver Colorado:

Blue Diamond Ventures Inc. (BLDV) adds depth to each of their major efforts in the Cannabis Industry by building out the Advisory Board.

- This is the first time I hear of a BLDV advisory board. Many times I see other companies issuing advisory board PRs that I would glance over only to see their pps start rising a while after the PR announcing an advisory board.

- I do not think a public company would add an advisory board unless they require subject matter experts, hence the word depth in the PR, on some significant/important projects. Members of the advisory board are not cheap to hire and I am presuming BLDV needs their expertise to satisfy some project and/or client service needs.

- Note the use of the word major efforts; BLDV MGMT is not the type to put such words in a PR unless they have something significant they are working on such as the Israeli projects, the Michigan Real Estate fund and AMS mentioned in this PR.

Medical Focus – Israeli Technologies, Targeted Therapies

Dr. Michele Ross joins as an important advisor to BLDV concerning current clinical trials, medical breakthroughs and synergies between researchers, patients and available therapies.

Dr. Michele Ross is Founder, Executive Director, and President of the Denver-based 501c3 nonprofit IMPACT Network. As a neuroscientist, she was frustrated by the lack of education on the endocannabinoid system both doctors and scientists received, despite medical cannabis being used by millions of patients nationwide. In 2013, she founded the “Endocannabinoid Deficiency Foundation,” now known as IMPACT Network, with the mission to make medical cannabis treatment a first-line therapy for patients by educating patients, healthcare professionals and policy makers and driving clinical cannabis research

- Notice how before introducing Dr. Ross, the PR mentions Medical Focus + Israeli Technologies + Targeted Therapies = I read this as saying BLDV has some major projects going on IMO.

- The PR further states that Dr. Ross will be an important advisor to BLDV concerning:

1. Current clinical trials

- Remember from the 6/12/17 PR when BLDV mentioned how the pharmaceutical industry is leveraging clinical trials performed in Israel. Key word is pharmaceutical industry and now BLDV has a doctor to advise them. I think this is major.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132355563&txt2find=trials

- Remember the Interview: CEO Joshua Alper of Blue Diamond Ventures, Inc. published on June 1, 2017 where BLDV CEO indicates that Israel is the only country in the world that is conducting cannabis clinical trials on humans - see 1:33:

2. Medical breakthroughs

- I am thinking this could possibly be the benefit of the Israeli technologies that BLDV will have access to.

3. Synergies between researchers, patients and available therapies

- This could be the value prospect that BLDV will be generating for its clients

AMS Farms Canada – Future home of Licensed Technology

- I do not think it gets clearer than this hint on the future of AMS with BLDV and how AMS will house the licensed technologies as part of their JV with AMS that was mentioned in the 4/20/17 PR:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=133175091&txt2find=ams

Joseph Groleau is Business Development Director and a Principle of Alternative Medical Solutions and joins as an advisor to BLDV for Canadian Business Ventures and Grow Operations.

- Another big hint on the future of BLDV in regards to Mr. Groleau advising BLDV on Canadian business ventures and grow operations. However, my question is why would they need Mr. Groleau as an advisor when he is already part of AMS. I am wondering if there is more than meets the eye to his advisory role in terms of what BLDV has going on.

Cannabis Real Estate & Technology Fund – Buildings, Licensed Brands and Specialized IP

Richard Paniagua joins the Advisory Board of BLDV with diverse Venture Capital, Investment, and Operational Management Experience including real estate, import/export, software development and agriculture.

- I think the investment, operational management, real estate and agriculture experience that Mr. Paniagua is bringing are relevant and indicative of the size of BLDV's efforts and requirements for the Michigan Growth Fund that were updated in the 6/21/17 PR:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132362093

In other News: Kenneth Teknus will be stepping down as a Consultant to BLDV, and will no longer be associated with the company. We thank Ken for his time with Blue Diamond Ventures and wish him the best in any future endeavors.

- I think this announcement demonstrates how BLDV is graduating to the next level by brining on new advisory board members to replace old consultants.

Source - 7/31/17 PR: http://www.otcmarkets.com/stock/BLDV/news?id=165842

Go BLDV!

JPS02

08/12/17 5:30 PM

#69085 RE: stervc #66595

Blue Diamond Consulting is currently assisting the BLDV legal team with the preparation of the Private Placement Memorandum that will finalize the parameters of the investment into AMS Farms (see below, AMS will retain their own debt and BLDV will not have liability for the 12 Million loan).

Extract from 7/17/17 PR: https://www.otcmarkets.com/ajax/showNewsReleaseDocumentById.pdf?id=26412

JPS02

08/15/17 9:03 PM

#69169 RE: stervc #66595

Key highlights and breakdown of BLDV 7/31/17 PR:

Blue Diamond Ventures Inc. Adds Three to Advisory Board

- Below are my thoughts on what I think is another loaded PR from BLDV demonstrating how BLDV's developing advisory board requirements are relevant follow through's on previous PRs.

BLDV Prepares for September Projects with Strategic Additions

- I think this subtitle is a key indicator of upcoming projects in September which I am presuming will be announced. This is my favour part of the PR. Key word is September.

July 31, 2017 Blue Diamond Ventures Inc. (OTC PK: BLDV) – Denver Colorado:

Blue Diamond Ventures Inc. (BLDV) adds depth to each of their major efforts in the Cannabis Industry by building out the Advisory Board.

- This is the first time I hear of a BLDV advisory board. Many times I see other companies issuing advisory board PRs that I would glance over only to see their pps start rising a while after the PR announcing an advisory board.

- I do not think a public company would add an advisory board unless they require subject matter experts, hence the word depth in the PR, on some significant/important projects. Members of the advisory board are not cheap to hire and I am presuming BLDV needs their expertise to satisfy some project and/or client service needs.

- Note the use of the word major efforts; BLDV MGMT is not the type to put such words in a PR unless they have something significant they are working on such as the Israeli projects, the Michigan Real Estate fund and AMS mentioned in this PR.

Medical Focus – Israeli Technologies, Targeted Therapies

Dr. Michele Ross joins as an important advisor to BLDV concerning current clinical trials, medical breakthroughs and synergies between researchers, patients and available therapies.

Dr. Michele Ross is Founder, Executive Director, and President of the Denver-based 501c3 nonprofit IMPACT Network. As a neuroscientist, she was frustrated by the lack of education on the endocannabinoid system both doctors and scientists received, despite medical cannabis being used by millions of patients nationwide. In 2013, she founded the “Endocannabinoid Deficiency Foundation,” now known as IMPACT Network, with the mission to make medical cannabis treatment a first-line therapy for patients by educating patients, healthcare professionals and policy makers and driving clinical cannabis research

- Notice how before introducing Dr. Ross, the PR mentions Medical Focus + Israeli Technologies + Targeted Therapies = I read this as saying BLDV has some major projects going on IMO.

- The PR further states that Dr. Ross will be an important advisor to BLDV concerning:

1. Current clinical trials

- Remember from the 6/12/17 PR when BLDV mentioned how the pharmaceutical industry is leveraging clinical trials performed in Israel. Key word is pharmaceutical industry and now BLDV has a doctor to advise them. I think this is major.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132355563&txt2find=trials

- Remember the Interview: CEO Joshua Alper of Blue Diamond Ventures, Inc. published on June 1, 2017 where BLDV CEO indicates that Israel is the only country in the world that is conducting cannabis clinical trials on humans - see 1:33:

2. Medical breakthroughs

- I am thinking this could possibly be the benefit of the Israeli technologies that BLDV will have access to.

3. Synergies between researchers, patients and available therapies

- This could be the value prospect that BLDV will be generating for its clients

AMS Farms Canada – Future home of Licensed Technology

- I do not think it gets clearer than this hint on the future of AMS with BLDV and how AMS will house the licensed technologies as part of their JV with AMS that was mentioned in the 4/20/17 PR:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=133175091&txt2find=ams

Joseph Groleau is Business Development Director and a Principle of Alternative Medical Solutions and joins as an advisor to BLDV for Canadian Business Ventures and Grow Operations.

- Another big hint on the future of BLDV in regards to Mr. Groleau advising BLDV on Canadian business ventures and grow operations. However, my question is why would they need Mr. Groleau as an advisor when he is already part of AMS. I am wondering if there is more than meets the eye to his advisory role in terms of what BLDV has going on.

Cannabis Real Estate & Technology Fund – Buildings, Licensed Brands and Specialized IP

Richard Paniagua joins the Advisory Board of BLDV with diverse Venture Capital, Investment, and Operational Management Experience including real estate, import/export, software development and agriculture.

- I think the investment, operational management, real estate and agriculture experience that Mr. Paniagua is bringing are relevant and indicative of the size of BLDV's efforts and requirements for the Michigan Growth Fund that were updated in the 6/21/17 PR:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132362093

In other News: Kenneth Teknus will be stepping down as a Consultant to BLDV, and will no longer be associated with the company. We thank Ken for his time with Blue Diamond Ventures and wish him the best in any future endeavors.

- I think this announcement demonstrates how BLDV is graduating to the next level by brining on new advisory board members to replace old consultants.

Source - 7/31/17 PR: http://www.otcmarkets.com/stock/BLDV/news?id=165842

Go BLDV!

JPS02

08/25/17 8:24 PM

#69650 RE: stervc #66595

http://www.cannabis-clean.com
http://www.clean1st.com
https://www.facebook.com/CannaClean/

Second Cannabis Cup in Everett ,WA!!!#CannabisCup #cannabis #Seattle pic.twitter.com/Lkue88TuT6
— Cannabis Clean (@CannabisClean) September 7, 2014

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126066472
https://www.facebook.com/108751362804882/photos/a.108785682801450.1073741827.108751362804882/434366133576735/?type=3&theater

7. BDC NY Solar Project: BDC is working on a community solar project in Western New York as per 10/26 PR

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126066472

8. BDC Consulting to MJ clients in Michigan: Signed multiple clients pursuing marijuana licenses under the new laws in Michigan as per 10/26 PR.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126066472

9. BDC Consulting to California Lights Works Cannabis LED Lighting: Signed a short-term consulting agreement with a Cannabis Greenhouse Systems as per 10/26 PR

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126066472

10. Collaboration with JUJU Joints: Vaporizer model is sold out online and BLDV presented products in Orlando in May 2016

http://www.jujujoints.com/juju
http://www.jujujoints.com/rx
https://www.facebook.com/permalink.php?story_fbid=253984474948236&id=108751362804882
http://www.bd-suiteofservices.com/attorneys.html
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126024509

11. Bot Bakery division of Michigan Plant Technologies: A 100% wholly owned subsidiary of Blue Diamond is an organic, vegan and gluten-free bakery and kitchen. Bot Bakery is working towards opening its 1st retail store in Chicago in the summer of 2017.

https://www.facebook.com/permalink.php?story_fbid=434293313584017&id=108751362804882
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131124591

12. 5/26/17 PR: Blue Diamond Ventures Inc. announces a strategic partnership with Eltron Research & Development of Boulder Colorado, the creators of the ImPAAct™ Peracetic Acid Generator: Eltron R&D specializes in Material Sciences and adds considerable strength to BLDV on multiple levels. Eltron R & D and BLDV join forces to make an ImPAAct(TM) (PAA) in the Cannabis Industry

5/26 PR: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures-Inc--announces-Strategic-Partnership?id=160232&b=y

Stervc's insight on Eltron:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131699192
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131716420
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131728225
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131716261
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131813616

Other thoughts:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131840197

Go BLDV!

JPS02

10/30/17 8:41 PM

#72300 RE: stervc #66595

Blue Diamond Ventures Inc. launches Israeli Operation to Develop Standards

New office for BLDV in Israel will manage the development of Sanitation & Cleaning Protocols for Cannabis-Clean

September 26, 2017 Blue Diamond Ventures Inc. (OTC PK: BLDV) Denver, Colorado / Tel-Aviv, Israel

Blue Diamond Ventures Inc. (BLDV) will open an Israeli office next month to manage the development of new Cleaning and Sanitation Protocols. The work product produced will become the core of Cannabis-Clean’s comprehensive offering directed at Cannabis Growers, Processors and Dispensaries. The new total facility approach will focus on a combination of procedures, equipment, supplies and training to build good sanitation practice into the design of new facilities, and retrofit when possible into existing cannabis facilities.

Cannabis-Clean has provided BLDV with a solid base in the Cannabis market in Colorado for over two years. Steve McMorrow, the President of Cannabis-Clean and a Director for BLDV says “We believe that the work being done in Israel will represent the state-of-the-art for sanitation in Cannabis Growing and Processing Facilities” McMorrow continued “It’s all about compliance, by adopting proven methods, growers can ensure that their products will pass the stricter testing being employed.”

Cannabis-Clean is transitioning from a janitorial type contractor to a “parts and smarts” approach to Sanitation and Cleaning. Leveraging the experience of Blue Diamond Consulting in building and construction, the new approach will produce a customized set of procedures for each facility. “We are using the same principles employed by the energy services sector” said Josh Alper CEO of BLDV, “Capture the data with a comprehensive building inspection, or review a set of plans, and then apply the proven solutions.”

Jonathan Alper will be back in Israel next week to finalize the new company. The office in Israel will initially be focused on the scope for Cannabis-Clean, and will then serve as a base to expand the goals of BLDV in Israel and pursue projects with local partners.

About BLDV:
Blue Diamond Ventures, Inc. is a diversified customer centric Management / Holding Company; Blue Diamond Ventures, Inc. seeks opportunities in various markets and is driven by critical thinking, the scientific method and compassionate ways to deliver sustainable results.

About Cannabis-Clean:
Cannabis-Clean is a trade name of Clean 1st LLC. (a wholly owned subsidiary of BLDV) Clean 1st / Cannabis Clean is a technology company that seeks to establish the standard for cleaning and sanitation in the Cannabis Industry. Focus on Education, Training, Proven Solutions and Reliable Equipment make Cannabis-Clean one of the leading brands in Colorado.

Safe Harbor:
This press release contains forward-looking statements. Such forward-looking statements are subject to several risks, assumptions, and uncertainties that could cause the Company's actual results to differ materially from those projected in such statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly revise any forward-looking statements.

Contact:
Blue Diamond Ventures Inc.
535 N. Michigan Avenue, Suite 3001, Chicago, Illinois, 60611
Joshua B. Alper Chief Executive Officer
(844) 637-6377 info@bldvinc.com www.bldvinc.com

Source: http://www.otcmarkets.com/ajax/showNewsReleaseDocumentById.pdf?id=27510

JPS02

10/30/17 9:17 PM

#72311 RE: stervc #66595

Blue Diamond Ventures Inc., Funding & Project Update

BLDV Secures Funding for Core Projects

October 23, 2017 Blue Diamond Ventures Inc. (OTC PK: BLDV)
Denver Colorado:

CEO Josh Alper of Blue Diamond Ventures Inc. (BLDV) provides answers to funding and revenue questions posed by the market.

What’s happening with AMS Farms Canada?

BLDV and AMS have a strategic partnership, we are less concerned with final debt structures and financing details, as these are defined by the PPM, and more interested in ensuring that AMS moves forward with a competitive advantage. This will be achieved by leveraging technologies, and assisting each other in meeting goals. Joseph Groleau from AMS joined our advisory board back in July and has already made an impact with the introduction to Quality Green Inc, our most recent Build to Lease client in Ontario. AMS and BLDV are moving forward with the joint venture effort of Blue Diamond Technologies, Canada, which will be the sister company of Blue Diamond Technologies, Israel. The two companies will provide a technology exchange mechanism between Canada and Israel for the Cannabis industry.

It is true that the 12 Million USD in funding for 50,000-sq. ft. AMS farm is taking longer than expected, but the landscape has changed as well. A recent decision was made by the province of Ontario to operate all the dispensaries. This decision makes growing licenses in Ontario more valuable and Health Canada is committed to help existing applicants to insure adequate supply. AMS is positioned well in this process, and may look to develop multiple locations simultaneously much like Quality Green Inc. BLDV is not prohibited from owning a Cannabis Farm in Canada.

How will BLDV fund its core projects?

BLDV received $100K in non-dilutive funding, from private investors, in October to fund operations. BLDV paid back $40K in short term loans, and retired 130 Million Shares back to the treasury. Revenues for group for the Quarter were up to $250K including Blue Diamond Consulting billing $50K for land development consulting fees in the 3rd Quarter of 2017, and increased revenues from MPT and the bettyBOT Shop.

BLDV in addition received $35K in deposits for build-to-lease projects in September & October of 2017.

Additional funding is always required, however the core Real Estate, Sanitation and Technology tracks in the Cannabis Sector can be safely secured and sustained until the projected revenues are attained.

BLDV is seeking to sell the existing 40% stake in Now Brands LLC, the maker of Olde Imperial

Mystic Vodka, the sale is related to the complications of being in both the Cannabis & Alcohol business. Federal compliance, state licenses, certifications, taxes, etc. The recent rebranding of the product has been warmly received by the market and I am still a believer in the product. Funds from the sale of Now Brands LLC will be used to finance a full audit of BLDV to reach the goal of SEC Reporting by June of next year.

How will the Cann10 North America Project be funded?

Cann10 North America is the single largest project that BLDV has taken on since I came on as CEO in March of 2016. Cann10 Israel is the leading Cannabis Group in the Israel, and focuses on Education, Conferences, Research and Technology, the new joint venture will be in Canada and will be responsible for driving a professional cannabis education effort, while planning a world class conference for late 2018. Cann10 North America will secure investment in the Cann10 Israel Technology Accelerator that will be the future of the cannabis Industry. The strict Bio-Tech approach to the Cannabis Space in the Cann10 Model is not the fastest path to revenue, but will create lasting significant profits and a sustainable competitive advantage.

Cann10 North America will sell equity to fund the startup of the Professional Education Programs in the USA and Canada, and enable the first Cann10 Medical Cannabis Conference in the USA in 2018.

How will the Cannabis Real Estate Projects be funded?

BLDV is the process of preparing a Private Placement Memorandum (PPM) for a 506(c) that will be used to raise the funds required to build, renovate, and/or acquire the facilities to lease to licensed cannabis operators. Documents have been contracted for the Michigan Properties and we are now working on the investment documents for the Canadian properties. Investors are limited partners in a real estate project. Multiple buildings are anticipated, each as a separate project.

How will Clean 1st, Cannabis Clean & Cannabis Clean Supply be funded?

BLDV is turning Cannabis Clean into a Technology Company combined with a Supply Division, having been in the Cannabis space for almost 4 years, Steve McMorrow has successfully managed to bring many collaborative partners to the table. Steve and I will be in Vegas together for the MJ Biz Conference in mid-November to describe the new format to the market in conjunction with a new web-site and e-store. BLDV is raising $150K for Cannabis Clean in a combination equity and debt format that will fund the transition.

About BLDV: Blue Diamond Ventures, Inc. seeks to partner with individuals and companies that share a common synergy, mission and vision to enable products/services that are produced, delivered and consumed utilizing fewer natural resources, providing a sustainable alternative to traditional products on the market today. As a diversified customer, centric Management / Holding Company; Blue Diamond Ventures, Inc. seeks opportunities in various markets and is driven by critical thinking and the scientific
method.

Safe Harbor: This press release contains forward-looking statements. Such forward-looking statements are subject to several risks,assumptions, and uncertainties that could cause the Company's actual results to differ materially from those projected in such statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly revise any forward-looking statements.

Contact:
Blue Diamond Ventures Inc.
535 N. Michigan Avenue, Suite 3001, Chicago, Illinois, 60611
Joshua B. Alper Chief Executive Officer
(844) 637-6377 info@bldvinc.com www.bldvinc.com

Source: https://www.otcmarkets.com/ajax/showNewsReleaseDocumentById.pdf?id=27854

JPS02

11/25/17 6:22 PM

#72932 RE: stervc #66595

At a Glance: Cannabis Taxation - Department of Finance of Canada

Date modified: 2017-11-10

The current approach to cannabis is not working, and the Government of Canada is committed to legalizing, regulating and restricting access to cannabis to keep it out of the hands of kids, and profits out of the hands of criminals. The Department of Finance Canada is consulting on a proposed new taxation regime on cannabis, which will help us achieve those goals, and is working with the provinces and territories to ensure a coordinated approach across the country.

Proposed Excise Duty Framework

The Government of Canada believes that the total of federal and provincial-territorial taxes on cannabis products should not exceed $1.00 per gram, or 10 per cent of the producer’s sale price of a product, and that this tax room should be shared equally between the two orders of government. The proposed federal excise duty rate would be 50 cents per gram of cannabis, or 5 per cent of the producer’s sale price of that product. An additional rate would apply for an agreeing province or territory.

The proposed duty would apply to all cannabis products available for legal sale, including fresh and dried cannabis, cannabis oils, as well as seeds and seedlings for home cultivation. The rate will also apply to the sale of medical cannabis.

It is important to note that excise duties are not paid directly by consumers. Rather, they are paid by manufacturers.

Application of Goods and Services Tax/Harmonized Sales Tax (GST/HST)

Cannabis product sales will be taxable under the Goods and Services Tax/Harmonized Sales Tax (GST/HST), as is currently the case for medical cannabis, for example.

Unlike the excise duty, GST/HST is paid directly by consumers at the point of sale.

The following example shows the final price paid by consumers at a combined rate of $1.00 per gram, or 10 per cent of the sale price:

One gram of dried cannabis

Pre-duty price: $8.00

Excise duty (per gram): $1.00

Subtotal: $9.00

GST/HST: $1.17

Total: $10.17

60 ml bottle of cannabis oil

Pre-duty price: $130.00

Excise duty (per cent): $13.00

Subtotal: $143.00

GST/HST: $18.59

Total: $161.59

***********
End of Extract
***********

Source: http://www.fin.gc.ca/n17/data/17-114_2-eng.asp

Secondary link to Proposed Excise Duty Framework for Cannabis Products that the Government of Canada is seeking feedback on: https://www.fin.gc.ca/n17/data/17-114_1-eng.asp

- I understand that the $8.00 is presented for illustrative purposes only; however, the total of federal and provincial-territorial taxes of $1.00 per gram, or 10 per cent of the producer’s sale price of a product that the Government of Canada is proposing has what I think is an imputed $10.00 per gram ceiling price ($1.00/10%). I could be wrong, if anyone has any thoughts please share them.

- Stervc, your valuation in your post #66595 (link back) assumes 30 million grams per harvest for AMS only. Assuming they obtain the funding, I think your valuation would yield revenues that are almost 2.7 times higher if we use the illustrative $8/gram (30 million grams x $8/gram = $240 million revenue per harvest approximately) which we could assume is the price before excise duties and taxes using what I think is the imputed price presented above. Do you agree? If yes, whenever you could kindly post an updated valuation post that would be greatly appreciated. Thank you.

Go BLDV!

JPS02

12/20/17 7:52 PM

#73290 RE: stervc #66595

BLDV + Quality Green: What we know so far

Note: Quality Green Inc. is a client of BLDV

1. Licensed Producer: Quality Green Inc. was added to the Health Canada web-site on Friday, October 27, 2017 making them the 39th licensed grower in Ontario.

Health Canada - List of Authorized Licensed Producers of Dried and Fresh Marijuana, and Cannabis Oil for Medical Purposes: Quality Green is on the list

Supporting link: https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-use-marijuana/licensed-producers/authorized-licensed-producers-medical-purposes.html

2. Quality Green Inc. website: Presented below are key extracts from Quality Green’s website:

i) We are a Licensed producer by Health Canada under the ACMPR to cultivate medical marijuana.

ii) Production Facilities - With our first facility completed we are excited to expand our operations to a second facility in 2018.

iii) Our short term vision is to have three facilities running year round . This will allow us to complete our aggressive growth strategy and become a household name for marijuana patients in legalized countries.

iv) Stay tuned, exciting updates are coming soon.

Source: http://qualitygreen.ca

3. Mention of Quality Green Inc. in BLDV PRs to date:

i) 9/6/17 BLDV PR - Blue Diamond Ventures Inc., Canadian Cannabis Update : Build to Lease Opportunity in Toronto- BLDV is in final negotiations with a Licensed Producer in Ontario to provide a turn-key design and build-to-lease building of 3,000 sq. ft. that will contain three levels of growing, for a total of 9,000 sq. ft. of grow space, with future expansion plans to build a 40,000-sq. ft. facility on the same site. Project should be confirmed within September. This project will be part of the newly expanded Innovative Growth Group Fund (Previously Michigan Growth Fund)

Source: https://www.otcmarkets.com/ajax/showNewsReleaseDocumentById.pdf?id=27159

ii) 9/20/17 BLDV PR - Blue Diamond Ventures Inc. Secures Canadian Real Estate Project: Blue Diamond Ventures Inc. (BLDV) has received a signed Letter-of-Intent and $25,000.00 deposit from Quality Green Inc. to provide a build-to-lease building for cannabis cultivation. This project is part of the newly expanded Innovative Growth Group Fund (Previously Michigan Growth Fund), that plans to build multiple buildings in the USA and Canada over the next 18 months. New Project will deploy a minimum of One Million (1 MM) USD from the Growth Fund

“Blue Diamond provided us with a package that will allow continued expansion to meet the surge in the Canadian market” said Andrew Spasiw, CEO of Quality Green Inc., “that, combined with access to the Blue Diamond’s network of technology and strategic partners, make it a powerful relationship”

Source: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures-Inc--Secures-Canadian-Real-Estate-Project?id=170323&b=y

iii) 10/19/17 PR - Blue Diamond Ventures Inc., Cannabis Clean Update: The Canadian GPP documents are incorporated as well to ensure that the new standards can be applied to Quality Green, AMS and other clients of BLDV. The new BLDV company formed in Israel this week will administer this project.

Source: https://www.otcmarkets.com/ajax/showNewsReleaseDocumentById.pdf?id=27825

iv) 10/23/17 PR - Blue Diamond Ventures Inc., Funding & Project Update : Joseph Groleau from AMS joined our advisory board back in July and has already made an impact with the introduction to Quality Green Inc, our most recent Build to Lease client in Ontario.

Source: https://www.otcmarkets.com/ajax/showNewsReleaseDocumentById.pdf?id=27854

v) 10/30/17 PR - BLDV Client, Quality Green Inc., Secures Licensed Producer Status: Blue Diamond Ventures, Inc. moves forward with $1mm USD Funding for New Facility. Blue Diamond Ventures, Inc. (OTC PINK: BLDV) will build a state of the art cultivation facility for the newest licensed producer in Ontario, Canada. Quality Green Inc. was added to the Health Canada web-site on Friday making them the 39th licensed grower in Ontario. Quality Green is now preparing for the future, even before their first test grow, they are already thinking expansion by planning an addition to the newly licensed facility in Canfield ON, making the BLDV turn-key project, the 3rd Cultivation Project for Quality Green Inc.

Pre-Fabricated Grow Rooms that jumpstart production, Vertical Growing Systems to optimize space, Heavy Duty Hydroponics to cut down on maintenance, and LED Lighting to enhance cannabinoids, are just a few of the products that will be specified for the new facilities during the next 60 days.

This first project is currently estimated at a cost of $1.2 Million USD, $700K for purchase of an existing building and an additional $500K for buildout and construction/project fees. BLDV is expected to deliver a fully functional cultivation facility within 12 months or the period approved by Health Canada.

Source: https://www.otcmarkets.com/stock/BLDV/news/BLDV-Client--Quality-Green-Inc---Secures-Licensed-Producer-Status?id=173711&b=y

vi) 11/21/17 PR - Blue Diamond Ventures Inc., Vegas Show Report : 1) Based on the performance of the Canadian Market, the size of the project has been increased and the building under consideration for purchase by BLDV for lease to Quality Green is now 30,000 sq. ft. up from 7,500 sq. ft.

2) BLDV was able to meet with the Quality Green team to further discuss the Site-B addition to their current Cannabis Cultivation License. The schedule for operations in the new building has been agreed to be January 2019, which matches the build-out plan and anticipated schedule of approvals from Health Canada.

3) Josh Alper CEO of BLDV will be in Canada on the week of December 5th to continue the process and inspect the buildings under consideration for purchase and build-out.

4) Andrew Spasiw, CEO of Quality Green Inc. was able to meet the team from Cann10 Israel to discuss how the efforts of Cann10 North America can contribute to a competitive sustainable advantage for their efforts in Canada.

Source: http://www.otcmarkets.com/ajax/showNewsReleaseDocumentById.pdf?id=28361

4. BLDV CEO Interviews:

i) 10/2/17 BLDV CEO interview: BLDV CEO discusses a few core details about the Quality Green agreement and the 506C structure of funding that makes this agreement happen in the YT clip below.

Quality Green Inc. is mentioned at the following YouTube clip intervals:

4:45 – Deal signed with Quality Green

5:15 – Explanation of how controlled distribution system provides opportunity to Quality Green where BLDV provides growing facility without having to apply for funding because they have a provincial government customer. Quality Green signed the LOI.

6:06 – Notice how the interviewer asks if BLDV will own 100% of Quality Green; however, BLDV CEO clarifies that BLDV will build and only own the growing facility for Quality Green.

ii) 12/4/17 BLDV CEO interview: BLDV discusses the following important developments about Quality Green in the YT clip below:

5:04 – BLDV took a bet with them that Quality Green would get their license

5:08 – Already have approval for construction of a new 15,000 sq. ft. facility .

5:16 – BLDV will provide a 30,000 sq. ft. (originally scheduled to be 7,500 sq. ft.) facility on the build lease program

5:27 – I think the key idea here that Josh mentions is how approvals from Health Canada encourage cannabis growers to expand and thereby provide supply. Furthermore, I think the supply capacity factor will affect future industry dynamics in Canada and the value prospect/attractiveness of new Licensed Produces such as Quality Green, a client of BLDV.

5:48 – Quality green took a chance by going through a very expensive multi-year process to get a 2,000 sq. ft facility approved

6:00 – BLDV took a chance with Quality Green that their timing is right and CEO indicates they both hit it very well and then he goes on to explain positive investment environment and expansion implications of timing.

- Based on the information presented above, I think there is a strong relationship developing between BLDV and their client Quality Green Inc. who is already licensed and has plans to build up to a total of 47,000 sq. ft (2,000 sq. ft. + 15,000 sq. ft. + 30,000 sq. ft.) of growing space .

Please share any comments or other thoughts you may have.

Go BLDV!

mikeski74

12/26/17 12:59 PM

#73555 RE: stervc #66595

Stervc great DD as always $BLDV will be a beast in 2018

mikeski74

12/26/17 1:01 PM

#73556 RE: stervc #66595

Weeeeeeeeeee great evaluation $BLDV

Hunchbackgeek

12/26/17 1:02 PM

#73558 RE: stervc #66595

$$BLDV You called it Stervc.

JPS02

01/30/18 10:05 PM

#74625 RE: stervc #66595

Key highlights of 12/21/17 PR: BLDV Acquires 25% of Cann10 North America Holdings Ltd.

Dec 21, 2017

OTC Disclosure & News Service

Chicago, IL. /Toronto, Canada, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Blue Diamond Ventures Inc. (OTC PK: BLDV), has completed the share purchase agreements with Cann10 North America Ltd. to acquire 25% of the shares in the newly formed venture. The acquisition will make BLDV the single largest shareholder in Cann10 North America, and Josh Alper, CEO of BLDV will have one of three seats on the board of directors. $750K in BLDV restricted shares and value added services are slated for this transaction, giving Cann10 North America an initial valuation of $3MM.

Cann10 North America Holding Ltd. is involved in the following activities:
-Expanding Trade and Business Activities of Cann10 to USA, Canada, Mexico, and Caribbean
-Offering Medical Cannabis Education and Courses in partnership with leading Universities.
-Offering new Investment Opportunities in Targeted Therapies & Medical Devices.
-Running the industry’s premiere Medical Cannabis Industry Conferences in North America.

“Cann10 North America is actively securing strategic partners” says Josh Alper, BLDV CEO. “This project touches everything we do and allows us to effectively use our network of trusted parties. Together we can provide education, access to investment in technologies and conferences all based on hard science and leading-edge research”.

The acquisition completes a promise made to BLDV shareholders to set the stage for significant revenue creation in 2018, with Global Partners focused on leading-edge Cannabis Research, Production and Clinical Trials

The new company, located in Canada has already captured the attention of multiple Licensed Producers (LP’s) in the rapidly expanding Canadian Cannabis Market, and has had offers of equity positions, consulting services, and more, based on access to the Israeli pipeline of products and IP, and the strong background of the team in providing Medical Education in the Global Cannabis Market.

Yossi Bornstein, CEO of Shizim Ltd, and Chairman of Cann10 International, stated "Blue Diamond Ventures offered us a unique combination of experience and knowledge for the North American market”.

The acquisition of shares in Cann10 North America, is in addition progress made on the other two main areas of focus by BLDV, Building and Leasing of facilities through the Innovative Growth Group (formally Michigan Growth Fund) and the newly re-launched Cannabis Sanitation efforts.

“The new tax laws favour the way our real-estate model is setup” said Jonathan Alper, Director in BLDV, Licensed Landscape Architect and the Master Planner for the real estate effort, “we could get up to an additional 5% return for our investors on the projects that are already forecasted.”

BLDV shares have shown significant movement this year and the operating divisions of the company are poised to become some of the leaders in the Medical Cannabis arena, corporate focus on the Adult-Use markets in both the USA and Canada, has opened Medical Cannabis opportunities for companies like BLDV and their strategic partners Cann10, AMS, Quality Green Inc., and others.

About BLDV:

BlueDiamond Ventures,Inc. is adiversified customer centric Management /Holding Company;BlueDiamond Ventures,Inc. seeks opportunities inmedical cannabis marketsand is driven by critical thinking, the scientific method and compassionate ways to deliver sustainable results

About Cann10:

Cann10 is a medical cannabis focused accelerator, offering selected entrepreneurs the advantages of high quality infrastructures, facilities, team, network, know-how and professional mentoring, tailored to support successful development, fund raising and commercialization of new technologies in this emerging field.

A collaboration between a leading Israeli authorized medical cannabis farm, and a leading Israeli holding and services group, Cann10 combines the respective expertise in the fields of medical cannabis and commercialization of medical devices and drugs, to support the introduction of new high value related products.

FORWARD LOOKING STATEMENT

This press release contains certain “forward-looking” statements, as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The Company, through its management, makes forward-looking public statements concerning it expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no factors that could cause actual results to differ materially from those estimated by the Company. They include, but are not limited to, the Company’s ability to develop operations, the Company’s ability to consummate and complete the acquisition, the Company’s access to future capital, the successful integration of acquired companies, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, sales and other factors that may be identified from time to time in the Company’s public announcements.

Source: Uptick Newswire
Contact:

BlueDiamond VenturesInc.

535N. MichiganAvenue, Suite 3001, Chicago, Illinois, 60611

JoshuaB.Alper Chief Executive Officer

(844)637-6377 info@bldvinc.com www.bldvinc.com

Copyright © 2017 GlobeNewswire. All Rights Reserved

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Source: https://www.otcmarkets.com/stock/BLDV/news/BLDV-Acquires-25--of-Cann10-North-America-Holdings-Ltd-?id=178788&b=y

https://globenewswire.com/news-release/2017/12/21/1269006/0/en/BLDV-Acquires-25-of-Cann10-North-America-Holdings-Ltd.html

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes: